coverage of secondary prophylaxis with antiplatelet medications (97.2%) and treatment for hypertension (73.9%) and diabetes (64.1%) was comparable to a previous hospital-based study conducted in Sri Lanka among 1000 patients who suffered from myocardial infarction and stroke which found that 76.9% were on aspirin, 19.6% were on statins and 44.2% and 39.2% were prescribed with beta-blockers and ACE Inhibitors respectively [14]. The gene discussed is ACE; the disease is hypertensive disorder.